New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

Imagine being one of the millions of Americans in need of a hip or knee replacement due to osteoarthritis. Severe pain, ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, manufactured by Novo Nordisk. Reuters Eli Lilly said Wednesday that its obesity drug Zepbound ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Many viewers of the 2025 Golden Globes quickly noticed stars who seemed to have embraced GLP-1 medications that help people ...

As former “Health and Wellness” columnist Sharon Gerdes wrote in her September column, one such ingredient that could be beneficial is Palatinose, Beneo’s patented isomaultulose, which can be used in ...

2024 was quite a year for significant strategic action among the pharmaceutical giants. Here are five key trends that will ...

Viking Therapeutics ( VKTX 4.30%) didn't exactly capture investors' hearts in the final month of 2024. The biotech company's ...

Nina King says that Ozempic's rise could shift beauty standards away from thinness as it becomes more accessible.

Millions of people have used Ozempic and similar drugs to lose weight, but are unhappy with the way their faces change, leading some to turn to a non-surgical treatment to flesh out their cheeks again ...